1405 related articles for article (PubMed ID: 25056892)
21. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients.
Peng H; Yang LT; Wang LY; Li J; Huang J; Lu ZQ; Koup RA; Bailer RT; Wu CY
Virology; 2006 Aug; 351(2):466-75. PubMed ID: 16690096
[TBL] [Abstract][Full Text] [Related]
22. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.
Netland J; DeDiego ML; Zhao J; Fett C; Álvarez E; Nieto-Torres JL; Enjuanes L; Perlman S
Virology; 2010 Mar; 399(1):120-128. PubMed ID: 20110095
[TBL] [Abstract][Full Text] [Related]
23. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
[TBL] [Abstract][Full Text] [Related]
24. Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope.
Oh HL; Chia A; Chang CX; Leong HN; Ling KL; Grotenbreg GM; Gehring AJ; Tan YJ; Bertoletti A
J Virol; 2011 Oct; 85(20):10464-71. PubMed ID: 21813600
[TBL] [Abstract][Full Text] [Related]
25. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.
Chen J; Lau YF; Lamirande EW; Paddock CD; Bartlett JH; Zaki SR; Subbarao K
J Virol; 2010 Feb; 84(3):1289-301. PubMed ID: 19906920
[TBL] [Abstract][Full Text] [Related]
26. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M
J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447
[TBL] [Abstract][Full Text] [Related]
28. Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.
Bošnjak B; Odak I; Barros-Martins J; Sandrock I; Hammerschmidt SI; Permanyer M; Patzer GE; Greorgiev H; Gutierrez Jauregui R; Tscherne A; Schwarz JH; Kalodimou G; Ssebyatika G; Ciurkiewicz M; Willenzon S; Bubke A; Ristenpart J; Ritter C; Tuchel T; Meyer Zu Natrup C; Shin DL; Clever S; Limpinsel L; Baumgärtner W; Krey T; Volz A; Sutter G; Förster R
Front Immunol; 2021; 12():772240. PubMed ID: 34858430
[TBL] [Abstract][Full Text] [Related]
29. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection.
Ng OW; Chia A; Tan AT; Jadi RS; Leong HN; Bertoletti A; Tan YJ
Vaccine; 2016 Apr; 34(17):2008-14. PubMed ID: 26954467
[TBL] [Abstract][Full Text] [Related]
30. Broad and strong memory CD4
Peng Y; Mentzer AJ; Liu G; Yao X; Yin Z; Dong D; Dejnirattisai W; Rostron T; Supasa P; Liu C; López-Camacho C; Slon-Campos J; Zhao Y; Stuart DI; Paesen GC; Grimes JM; Antson AA; Bayfield OW; Hawkins DEDP; Ker DS; Wang B; Turtle L; Subramaniam K; Thomson P; Zhang P; Dold C; Ratcliff J; Simmonds P; de Silva T; Sopp P; Wellington D; Rajapaksa U; Chen YL; Salio M; Napolitani G; Paes W; Borrow P; Kessler BM; Fry JW; Schwabe NF; Semple MG; Baillie JK; Moore SC; Openshaw PJM; Ansari MA; Dunachie S; Barnes E; Frater J; Kerr G; Goulder P; Lockett T; Levin R; Zhang Y; Jing R; Ho LP; ; ; Cornall RJ; Conlon CP; Klenerman P; Screaton GR; Mongkolsapaya J; McMichael A; Knight JC; Ogg G; Dong T
Nat Immunol; 2020 Nov; 21(11):1336-1345. PubMed ID: 32887977
[TBL] [Abstract][Full Text] [Related]
31. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
Laczkó D; Hogan MJ; Toulmin SA; Hicks P; Lederer K; Gaudette BT; Castaño D; Amanat F; Muramatsu H; Oguin TH; Ojha A; Zhang L; Mu Z; Parks R; Manzoni TB; Roper B; Strohmeier S; Tombácz I; Arwood L; Nachbagauer R; Karikó K; Greenhouse J; Pessaint L; Porto M; Putman-Taylor T; Strasbaugh A; Campbell TA; Lin PJC; Tam YK; Sempowski GD; Farzan M; Choe H; Saunders KO; Haynes BF; Andersen H; Eisenlohr LC; Weissman D; Krammer F; Bates P; Allman D; Locci M; Pardi N
Immunity; 2020 Oct; 53(4):724-732.e7. PubMed ID: 32783919
[TBL] [Abstract][Full Text] [Related]
32. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.
Rockx B; Corti D; Donaldson E; Sheahan T; Stadler K; Lanzavecchia A; Baric R
J Virol; 2008 Apr; 82(7):3220-35. PubMed ID: 18199635
[TBL] [Abstract][Full Text] [Related]
34. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.
Iwata-Yoshikawa N; Uda A; Suzuki T; Tsunetsugu-Yokota Y; Sato Y; Morikawa S; Tashiro M; Sata T; Hasegawa H; Nagata N
J Virol; 2014 Aug; 88(15):8597-614. PubMed ID: 24850731
[TBL] [Abstract][Full Text] [Related]
35. Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells.
Zhong W; Roberts AD; Woodland DL
J Immunol; 2001 Aug; 167(3):1379-86. PubMed ID: 11466356
[TBL] [Abstract][Full Text] [Related]
36. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
Hu H; Lu X; Tao L; Bai B; Zhang Z; Chen Y; Zheng F; Chen J; Chen Z; Wang H
Clin Vaccine Immunol; 2007 Jul; 14(7):894-901. PubMed ID: 17494640
[TBL] [Abstract][Full Text] [Related]
37. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates.
Liu SJ; Leng CH; Lien SP; Chi HY; Huang CY; Lin CL; Lian WC; Chen CJ; Hsieh SL; Chong P
Vaccine; 2006 Apr; 24(16):3100-8. PubMed ID: 16494977
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
[TBL] [Abstract][Full Text] [Related]
39. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
[TBL] [Abstract][Full Text] [Related]
40. Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a.
Kohyama S; Ohno S; Suda T; Taneichi M; Yokoyama S; Mori M; Kobayashi A; Hayashi H; Uchida T; Matsui M
Antiviral Res; 2009 Nov; 84(2):168-77. PubMed ID: 19748524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
